Karuna Therapeutics, Inc.
KRTX · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $11,698 | $6,215 | $3,817 | $2,687 |
| - Cash | $186 | $248 | $207 | $53 |
| + Debt | $17 | $5 | $8 | $3 |
| Enterprise Value | $11,529 | $5,972 | $3,618 | $2,636 |
| Revenue | $1 | $11 | $37 | $0 |
| % Growth | -93.9% | -71.2% | – | – |
| Gross Profit | -$1 | $10 | $36 | -$0 |
| % Margin | -160.1% | 89.5% | 98.6% | – |
| EBITDA | -$493 | -$260 | -$143 | -$69 |
| % Margin | -75,393.9% | -2,440.8% | -387.3% | – |
| Net Income | -$434 | -$276 | -$144 | -$69 |
| % Margin | -66,311.9% | -2,597.9% | -389% | – |
| EPS Diluted | -11.73 | -8.74 | -4.94 | -2.59 |
| % Growth | -34.2% | -76.9% | -90.7% | – |
| Operating Cash Flow | -$386 | -$228 | -$101 | -$70 |
| Capital Expenditures | -$3 | -$1 | -$3 | -$0 |
| Free Cash Flow | -$389 | -$229 | -$104 | -$70 |